Overview
- Functions as a resource for new treatments for patients with heart failure and diabetes mellitus
- Offers comprehensive information for physicians interested in stem cell technology
- Provides a template for others to develop stem cell treatments in their specialty
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (36 chapters)
-
Front Matter
-
Heart Failure (United States)
-
Front Matter
-
-
Heart Failure (Europe)
-
Front Matter
-
-
Heart Failure (China)
-
Front Matter
-
Keywords
About this book
This book examines the application of stem cell surgery for diabetes and heart failure.
Organized into two sections, the first identifies and summarizes the current worldwide stem cell trials for heart failure. Subsequent chapters in part two analyze the current worldwide stem cell trials in patients with Diabetes Mellitus. Both sections utilize studies that include non-expanded stem cells; each study is grouped by stem cell type and geographic location.
Stem Cell Surgery Trials in Diabetes and Heart Failure is a comprehensive, convenient reference for cardiologists, endocrinologists, internists, and family physicians.
Authors and Affiliations
About the author
Jeffrey N. Weiss, M.D.
The Healing Institute
Margate, FL
USA
Jeffrey N. Weiss, MD is the former Chief of Retinal Surgery at the Joslin Diabetes Center in Boston, Faculty of Harvard Medical School, and Visiting Scientist at the Massachusetts Institute of Technology. He entered college at 16 years of age, and medical school at age 19 on full scholarships. While in medical school he obtained a degree in Electrical Engineering, Magna Cum Laude with distinction, and graduated from Medical School, Summa Cum Laude, at 23 years of age.
Dr. Weiss is the author of more than 100 publications, including 11 books, holds more than 20 U.S. and foreign patents, and has been a Reviewer for multiple scholarly journals. He has served as a Visiting Professor, performed surgery, and lectured nationally and internationally. Dr. Weiss is also the founder of two companies, Ocular Research Associates Inc., and Micron Ophthalmic, Inc. which have manufactured and sold Dr. Weiss’ inventions worldwide.
Dr. Weiss performed the first retinal stem cell surgery in the world in 2010 and is the Principal Investigator of The Stem Cell Ophthalmology Treatment Studies I/II, the largest retinal and optic nerve stem cell studies in the world, The Neurologic Stem Cell Treatment Study, The Stem Cell Spinal Cord Injury Exoskeleton and Virtual Reality Treatment Study, and The Alzheimer’s, Cognitive Impairment and Autism Treatment Study. The studies are Institutional Review Board (IRB) approved, registered with NIH and listed on ClinicalTrials.gov.
Dr. Weiss first visited Dubai in 2008, where equipment he had invented was being showcased at Arab Health, the second largest medical equipment meeting in the world. In 2015, he obtained a Dubai medical license and has been travelling to Dubai to examine patients, perform surgery and lecture. His work has been featured in all the major Dubai newspapers and television. He was a finalist for the United Arab Emirates HealthCare Award in 2018 and 2019.
Bibliographic Information
Book Title: Stem Cell Surgery Trials in Heart Failure and Diabetes
Book Subtitle: A Concise Guide
Authors: Jeffrey N. Weiss
DOI: https://doi.org/10.1007/978-3-030-78010-4
Publisher: Springer Cham
eBook Packages: Medicine, Medicine (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022
Softcover ISBN: 978-3-030-78009-8Published: 24 March 2022
eBook ISBN: 978-3-030-78010-4Published: 23 March 2022
Edition Number: 1
Number of Pages: X, 194
Topics: Surgery, Cardiology, Endocrinology, Stem Cells